Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing
Abstract Broadly neutralizing antibodies (bNAbs) targeting the HIV-1 envelope glycoprotein (Env) have the capacity to delay viral rebound when administered to people with HIV-1 (PWH) during anti-retroviral therapy (ART) interruption. To further enhance the performance of bNAbs through their Fc effec...
Huvudupphovsmän: | Steven W. de Taeye, Angela I. Schriek, Jeffrey C. Umotoy, Marloes Grobben, Judith A. Burger, Rogier W. Sanders, Gestur Vidarsson, Manfred Wuhrer, David Falck, Neeltje A. Kootstra, Marit J. van Gils |
---|---|
Materialtyp: | Artikel |
Språk: | English |
Publicerad: |
Nature Portfolio
2024-08-01
|
Serie: | Communications Biology |
Länkar: | https://doi.org/10.1038/s42003-024-06659-8 |
Liknande verk
Liknande verk
-
PP 8.8 – 00129 Antibody mediated killing of HIV-1 infected cells with glycoengineered broadly neutralizing antibodies
av: S. De Taeye, et al.
Publicerad: (2022-12-01) -
A functional spleen contributes to afucosylated IgG in humans
av: Iwona Wojcik, et al.
Publicerad: (2021-12-01) -
Acquisition of Fc-afucosylation of PfEMP1-specific IgG is age-dependent and associated with clinical protection against malaria
av: Mary Lopez-Perez, et al.
Publicerad: (2025-01-01) -
Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
av: Angela I. Schriek, et al.
Publicerad: (2022-11-01) -
Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
av: Angela I. Schriek, et al.
Publicerad: (2022-05-01)